C07D 295/20
By radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
Official title: by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
C07D295/20 (By radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof) appears on 1,132 US grants and 751 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,132
- Published applications
- 751
- Assignees
- 559
- Inventors
- 3,474
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 25 | 0 |
| 1977 | 29 | 0 |
| 1978 | 35 | 0 |
| 1979 | 21 | 0 |
| 1980 | 11 | 0 |
| 1981 | 22 | 0 |
| 1982 | 19 | 0 |
| 1983 | 26 | 0 |
| 1984 | 23 | 0 |
| 1985 | 17 | 0 |
| 1986 | 30 | 0 |
| 1987 | 17 | 0 |
| 1988 | 17 | 0 |
| 1989 | 14 | 0 |
| 1990 | 22 | 0 |
| 1991 | 13 | 0 |
| 1992 | 20 | 0 |
| 1993 | 16 | 0 |
| 1994 | 18 | 0 |
| 1995 | 17 | 0 |
| 1996 | 25 | 0 |
| 1997 | 38 | 0 |
| 1998 | 36 | 0 |
| 1999 | 23 | 0 |
| 2000 | 35 | 0 |
| 2001 | 32 | 8 |
| 2002 | 44 | 54 |
| 2003 | 33 | 55 |
| 2004 | 28 | 65 |
| 2005 | 24 | 48 |
| 2006 | 28 | 34 |
| 2007 | 34 | 42 |
| 2008 | 29 | 49 |
| 2009 | 27 | 32 |
| 2010 | 35 | 38 |
| 2011 | 19 | 33 |
| 2012 | 18 | 16 |
| 2013 | 25 | 24 |
| 2014 | 25 | 27 |
| 2015 | 20 | 27 |
| 2016 | 21 | 20 |
| 2017 | 27 | 23 |
| 2018 | 18 | 18 |
| 2019 | 12 | 11 |
| 2020 | 7 | 12 |
| 2021 | 10 | 15 |
| 2022 | 8 | 25 |
| 2023 | 10 | 22 |
| 2024 | 11 | 23 |
| 2025 | 14 | 14 |
| 2026 | 4 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine19 May 2026US 12,630,487 B2Otsuka Pharmaceutical Co., Ltd.
- Compound as a UBR box domain ligand24 Feb 2026US 12,559,455 B2Autotac Inc.
- Composition for tin-silver alloy electroplating comprising a complexing agent24 Feb 2026US 12,559,852 B2BASF SE
- Compound as a UBR box domain ligand30 Dec 2025US 12,509,420 B2Autotac Inc.
- Cobalt-catalyzed carbonylative alkene hydrofunctionalizations promoted by visible light8 Oct 2026US 2026/0308103 A1
- Inhibitors of spinster homolog 2 (spns2) for use in therapy1 Oct 2026US 2026/0297044 A1University of Virginia Patent Foundation
- Memantyl urea derivative, preparation method thereof, and use thereof in preparation of drug for treating soluble epoxide hydrolase-mediated disease6 Aug 2026US 2026/0224548 A1Guangdong Hongshanhu Pharmaceutical Co., Ltd.
- Visible light driven co2 valorization6 Aug 2026US 2026/0225999 A1The Board of Regents for the Oklahoma Agricultural and Mechanical Colleges
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Compositions for oral delivery of active agents159US 5,650,386 AEmisphere Technologies, Inc. · 1997
- Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof134US 4,977,277 AAbbott Laboratories · 1990
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997
- Compounds and compositions for delivering active agents125US 5,866,536 AEmisphere Technologies, Inc. · 1999